Nucleosomal DNA Proficiency Standards for Genetic Diagnostics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for non-invasive prenatal genetic diagnostics and cancer cell DNA detection using cell-free DNA are complex and prone to errors due to the scarcity of naturally occurring samples and variability, making it challenging for commercial laboratories to demonstrate proficiency and obtain regulatory approval.
Innovation Solution
Development of nucleic acid proficiency testing standards comprising nucleosomal nucleic acid preparations from different cell sources, allowing for the creation of standardized compositions that simulate various fetal or cancer cell fractions, enabling accurate and reliable testing by mimicking natural cell-free DNA samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If naturally occurring cell-free DNA samples are used for proficiency testing, then the authenticity and biological relevance of the testing standard is improved, but the availability and reproducibility deteriorate due to scarcity and variability between samples
Solution Approach 1:
The patent creates artificial copies of cell-free DNA that replicate the biological characteristics of naturally occurring samples. By synthesizing DNA fragments with specific nucleosomal patterns and fragment size distributions that mirror authentic cell-free DNA, the invention produces reproducible testing standards without relying on scarce natural samples. The artificial samples are designed to contain fetal-derived and maternal-derived DNA sequences in realistic proportions, enabling laboratories to perform proficiency testing with consistent, available materials while maintaining biological authenticity.
2Measurement precision
If complex methods are used for non-invasive prenatal genetic diagnostics, then the detection capability is improved, but the error rate and operational difficulty increase
Solution Approach 1:
The patent optimizes specific parameters of the testing standard to improve detection while simplifying methodology. By carefully controlling the fragment size distribution, nucleosomal pattern characteristics, and relative proportions of fetal versus maternal DNA sequences in the artificial cell-free DNA samples, the invention creates testing standards that enable accurate detection with streamlined procedures. The standardized parameters ensure consistent test performance across different laboratories, reducing operational complexity while maintaining high detection precision for fetal aneuploidy and other genetic conditions.
3Manufacturing precision
If standardized nucleic acid preparations are created from multiple cell sources, then the accuracy of simulating fetal DNA fractions is improved, but the manufacturing complexity increases
Solution Approach 1:
The patent divides the manufacturing process into distinct segments, each handling specific DNA preparations from different cell sources. The method separates the preparation of fetal-derived DNA fragments and maternal-derived DNA fragments into independent steps, then combines them in controlled ratios to achieve accurate fetal DNA fraction simulation. This segmented approach allows each segment to be optimized independently for quality while maintaining overall manufacturing efficiency. The standardized segmentation enables different laboratories to produce consistent testing standards using their own cell sources, reducing the burden of complex centralized manufacturing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of these standards facilitates the production of large quantities of genetic testing standards, improving the accuracy and reliability of prenatal and cancer cell DNA diagnostics, thereby aiding in the commercialization and regulatory approval of testing procedures.
Implementation Method 1
nucleosomal nucleic acid preparation has been prepared with an endonuclease. The endonuclease can be a micrococcal endonuclease
Data Source
AI summary
Embodiments of the invention include methods and compositions for producing proficiency testing standards for noninvasive prenatal genetic diagnostics and for the detection and monitoring of cancer. The compositions can include a plurality of different nucleosomal DNA fragments derived from either primary cells or cell lines. The amount of the different nucleosomal DNA fragments can be varied so as to simulate naturally occurring cell free DNA samples obtained from the blood of the pregnant woman or naturally occurring cell free DNA samples obtained from the blood of cancer patients.